EndocrinolJapon 1991,38(5),465-470

A Case of Diabetic Non-Ketotic Hyperosmolar Coma with an Increase with Plasma 3-Hydroxybutyrate

OSAMUKINOSHITA*, IzuRu MASUDA, MASAAKISUZUKI, MoTOO TSUSHIMA, YASUKONISHIOEDA, TATSUOMATSUYAMA, HIDETOKOJIMA**, ANDYUTAKA HARANO Divisionof Atherosclerosis, Metabolism and ClinicalNutrition, National CardiovascularCenter, Osaka 565, *FirstDep. of ,Shinshu University Medical School, Matsumoto 309, and **ThirdDepartment of Medicine, Shiga Universityof MedicalScience, Ohtsu 520-21, Japan

Abstract. We have seen a case of "diabetic non-ketotic hyperosmolar coma" with ketosis. An 84-year-old man was brought into the hospital in a deeply comatous and dehydrated state. The initial blood glucose level was 1252mg/dl with plasma osmolarity of 435 mOsm/l, but no ketonuria was detected by the nitroprusside method (Ketostix). However, the plasma 3-hydroxybutyrate (3-OHBA) level was 5 mM in a newly developed bedside film test. The serum ketone bodies were later found to be 5.56 and 0.82 mmol/l for 3-OHBA and acetoacetate (AcAc), respectively. A marked increase in glucagon, cortisol and ADH with renal dysfunction (creatinine 5.0 mg/dl) were noted. An abnormal electrocardiogram, occular convergence and chorea like movement disappeared after correction of metabolic disturbances. The moderate level of IRI (14 p J/ml) on admission and a good response to glucagon 2 months after admission also indicate that the present case is a typical hyperosmolar non-ketotic coma. Because of a preferential increase in 3-OHBA, ketonuria seemed to be absent in the regular nitroprusside test. Marked dehydration is thought to cause renal dysfunction, and the increase in ADH may have helped to prevent further aggravation of ketoacidosis. We propose to change the term hyperosmolar non-ketotic coma (HNC) to diabetic hyperosmolar coma (DHC), because sometimes patients with hyperosmolar non-ketotic diabetic coma are ketotic, as seen in the present case. Determination of 3-OHBA or individual ketone bodies in blood is important and essential for the differential diagnosis of diabetic coma. The diagnosis of either ketoacidotic or hyperosmolar coma should be made depending on the major expression of ketoacidosis or hyperglycemic hyperosmolarity.

Keywords: Hyperosmolar diabetic coma, Ketoacidosis,Ketogenesis, ADH, C-kinase. (EndocrinolJapon 38: 465-470, 1991)

THE HYPERGLYCEMIC hyperosmolar non- background and features of ketoacidosis and ketotic coma is characterized by severe hyper- hyperosmolar nonketotic coma are quite different. glycemia, hyperosmolarity and dehydration in the The former is characterized by acute onset in absence of ketoacidosis [1-7]. But recently we have insulin dependent mellitus (IDDM) in seen a case of hyperglycemic hyperosmolar coma young patients and proceeds to permanent di- with significant ketosis and acidosis. The clinical abetes after a remission period. The latter occurs in aged non-insulin dependent diabetes mellitus Received: July 2, 1990 (NIDDM) patients with frequent association of Accepted: August 6, 1991 reversible renal dysfunction and usually pancrea- Correspondence to: Dr. Yutaka HA RANO, Division of Ather- tic beta cell function is maintained. In the present osclerosis, Metabolism and Clinical Nutrition, National Car- diovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565, case, in spite of the presence of ketoacidosis, the Japan. overall clinical features were regarded as those of 466 KINOSHITA et al. the latter type because of the onset of marked the right. Ankle reflex was absent, and pain hyperglycemia, dehydration and uremia in sensation in the lower extremities was markedly NIDDM with subsequent recovery of pancreatic decreased, indicating the presence of diabetic beta cell function. neuropathy.

Laboratory Findings (Table 1) Subject and Clinical Course An 84-year-old man was brought into our clinic The following values were abnormally in- in an obtunded state. A diagnosis of diabetes creased: hematocrit 58.9%, white blood cell count mellitus had been made at the age of 59. He had 2280/mm3, blood glucose 1252 mg/dl, BUN 175 been treated with diet alone or on occasion with mg/dl and serum creatinine 5.0 mg/dl. Electrolyte oral hypoglycemic agents. He had experienced values, sodium (143 mEq/l) and chloride (93 polydipsia and polyuria 2 weeks before. On week mEq/l) were normal, but an increase in potassium prior to admission he could not eat enough (7.4 mEq) and a decrease in bicarbonate (11.7 because of soreness around the month due to mEq/l) were noted. The arterial blood pH was stomatitis. About three days before admission, he 7.25, PCO2 was 27.6 mmHg with a base excess of had been drowsy, and in the morning of admission -14 .1mEq/1. The anion gap was 38.3 mEq/l. he was found in a confused state in bed, difficult to Urinary glucose was markedly positive, but urin- arouse, and became unconscious by the time of his ary ketone test with the nitroprusside method admission. (Ketostix) was negative. The plasma level of He was slightly overweight (Height; 145.5cm, 3-OHBA in bedside film test was 5.0 mM on Body Weight; 48.5 kg) and respiration was deep admission and was later found to be 5.6 mM/l with with a rate of 20/min, but no acetone odor was 0.8 mM/l AcAc in a direct enzymatic assay. The noted. The systolic was low (60 clinical course of the patient is depicted in Figs.1 mmHg), and the heart rate was 72 per min. The and 2. After the continuous infusion of a small skin turgor had markedly decreased. The neck dose (4-10 U/h) of intravenous insulin and 5 liters veins were not visible. There was a grade I of saline, blood glucose and ketone bodies steadily precordial systolic murmur. The lung sound was decreased and fell below 20% of the basal value at clear. There was conjugate deviation of the eye to 12 h. Consciousness was gradually restored 24 h

Table 1. Laboratory data HYPEROSMOLAR COMA 467

Fig.1. Effect of insulin and fluid therapy for a patient with hyperosmolar diabetic coma. ADH: antidiuretic hormone, BE: base excess, Cr: creatinine, GH: growth hormone, IRG: Immuno reactive glucagon (P; pancreatic, T; total), IRI: immunoreactive insulin, 3-OHBA: 3-hydroxybutyric acid.

after admission. An inverted T wave in the ECG Discussion observed on admission and which became promin- ent during the initial fluid and insulin therapy The diabetic "non-ketotic" hyperosmolar coma subsequently normalized during a course of meta- often observed in patients with NIDDM has been bolic correction. In addition, chorea-like move- characterized by extreme hyperosmolar hyper- ments in the right leg which were induced during glycemia without ketoacidosis. As a result of the hyperosmolar coma disappeared during tiapride marked degree of hyperglycemia and glycosuria, administration days 40-50. MRI of the brain patients became severely dehydrated with a great exhibited multiple cerebral infarction. Insulin loss of glucose, sodium and water in urine. The sensitivity for glucose utilization assessed by the progressing dehydration leads to deteriorated SSPG (steady state plasma glucose) method was renal function, reducing the capacity of the kidney normal (106mg/dl, Fig.3). Plasma levels of ketone to excrete glucose and further aggravating the bodies were well suppressed 2 h after the insulin hyperglycemic state. The reason for the absence of infusion, indicating normal insulin sensitivity in significant ketosis in this syndrome has been as well as in the liver. The effect of speculated by many investigators. Joffe and associ- the combined intravenous glucagon (1 mg) and ates suggested that the lack of ketosis may be glucose on insulin secretion was normal during the explained by the metabolism of incoming free 50 day period of the admission. fatty acid along non-ketogenic pathways (ester- ification) in the liver [8]. Gerich et al. reported that dehydration and hyperosmolarity themselves sup- press lipolysis, thus contributing to the non-ketotic 468 KINOSHITA et al.

Fig.2. Clinical course of a patient with hyperosmolar diabetic coma. FPG: fasting plasma glucose.

Fig. 3. Insulin sensitivity test.

Glucose (12% solution, 6 mg/kg/min), monocompo- nent act-rapid human insulin (0.77 mU/kg/min), and

somatostatin (250ƒÊg/h) were infused for 2h through an antecubital vein via a constant infusion

pump. Steady state plasm glucose (SSPG) levels at 2 h were measured. HYPEROSMOLAR COMA 469

syndrome [9]. Recently Kojima et al. reported that increase in AcAc (0.85 mmol/l), indicating the vasopressin suppresses glucagon or epinephrine- presence of ketosis in hyperosmolar coma. stimulated ketogenesis through activation of c- Altogether we saw 7 so-called non-ketotic hyper- kinase in isolated hepatocytes [10]. Harano et al. osmolar diabetic coma cases. They all exhibited mild or non-ketouria (2 subjects:+, 2:•}, 3:-). proposed that blood vasopressin which is known to have a hyperglycemic effect and is high in the Five out of six in whom ketone bodies were dehydrated hyperosmolar state plays a suppressive determined had ketosis exceeding total ketone role in hepatic ketogenesis. Therefore, suppres- bodies more than 1 mM (3-OHBA/AcAc=1.4 to sion of ketogenesis while enhancing hyper- 7), indicating that mild ketonemia is a rather common finding in hyperosmolar diabetic coma. glycemia by vasopressin may be an important factor in the pathophysiology of hyperglycemic The present case is an extreme case of this hyperosmolar coma [11]. In fact, the initial vasop- syndrome who exhibited no ketonuria but had a ressin level in the blood was greatly increased (58 total ketone body level of 6.4 mM with a high ratio of 3-OHBA/AcAc (=7). pg/ml) in our patient, but failed to suppress ketoacidosis. Without this increase, severer Among ketone bodies, AcAc reacts with nitro-

ketoacidosis may have developed. Vasopressin prusside reagent (Ketostix), but 3-OHBA failed to alone cannot explain the mechanism, but it should react with this reagent at all. In our patient, a

be considered as one of the regulatory hormones prominent increase in the 3-OHBA/AcAc ratio in the pathophysiology of non-ketotic diabetic caused a negative nitroprusside reaction in the

coma. Glucagon is known to stimulate hepatic urine and blood. Since our patient had a marked ketogenesis [12, 13]. In the present case, pancrea- decrease in the extracellular fluid volume and

tic glucagon was markedly increased (720ƒÊg/ml). deteriorated into a state of so-called hypovolemic The mechanism of a further increase in pancreatic shock, an adequate supply of oxygen could not be delivered to tissues, resulting in a preponderant glucagon to 1600ƒÊg/ml and the disappearance of increase in 3-OHBA over AcAc. The equilibrium gut glucagon after insulin and fluid therapy remain to be elucidated. between AcAc and 3-OHBA is determined in large

Halperin et al. reported recently that ketosis is part by the ratio of reduced and oxidized NAD in an inevitable consequence of the hyperglycemic mithochondria. Hypoxia with an increased level of

hyperosmolar syndrome and the increased 3- NADH is thought to drive the reaction toward OHBA is thought to facilitate its metabolism in the 3-OHBA [16]. central nervous system [ 14]. In fact, analysis of The pathogenic spectrum of acutely decompen-

over 1000 cases of acutely decompensated diabetes sated diabetes mellitus ranges from pure hyper- mellitus at Gray Memorial Hospital from mid- osmolar hyperglycemia without ketosis, to mixed

1973 to mid-1975 revealed that about 67% of the hyperosmolar hyperglycemia and ketosis or ketoacidosis and to almost pure ketoacidosis with- patients had mild or moderate ketoacidosis and about 25% had severe ketoacidosis (HCO3< 10 out significant hyperosmolar hyperglycemia [17]. mEq/l, serum osmolarity> 350 mOsm/l). Two Nevertheless, until recently, detection of a clinical increase in ketosis tends to depend on the nitro- percent had a pure hyperglycemic hyperosmolar state (serum osmolarity> 350 mOsm/l without prusside test in most of the diabetes clinics. A ketonemia or ketonuria), and 1% had almost pure bedside film test and direct enzymatic assay severe diabetic ketoacidosis (HCO3< 10 mEq/l, method for 3-OHBA or individual ketone bodies are now available and essential for the diagnosis of glucose > 150 mg/dl) [ 15]. Therefore, it is postu- lated that most of the patients with "non-ketotic" ketotic or non-ketotic diabetic coma [18, 19]. An

hyperosmolar coma were at least ketonemic when increase in 3-OHBA is possibly a rather common ketone bodies were properly determined. In fact, finding in hyperosmolar coma. Therefore, we we had seen a similar case, a 66-year-old female propose that the term "hyperosmolar nonketotic with hyperglycemia (587 mg/dl) and hyperosmo- coma (HNC)" should be changed to "diabetic larity (403 mOsm/l) but without ketonuria; but her hyperosmolar coma (DHC)". blood 3-OHBA was 1.6 mmol/l with a slight 470 KINOSHITA et al.

References 1. Benedetto RJ, Crocco JA, Soscia JL (1965) Recent Progress in Posterior Pituitary Hormones Hyperglycemic non-ketotic coma. Arch Intern Med 1988. Elsevier Science Publishers B. V. 395-400. 116: 74-82. 12. Keller U, Chiasson J, Liljenquist JE, Cherrington 2. Dreschfeld J (1886) The bradshaw lecture on AD, Jennings AS, Crofford OB (1977) The role of diabetic coma. Br Med J 2: 358-363. insulin, glucagon, and free fatty acids in the 3. Gerich J, Martin MM, Recant L (1971) Clinical and regulation of ketogenesis in dogs. Diabetes 26: metabolic characteristics of hyperosmolar nonketo- 1040-1051. tic coma. Diabetes 20: 228-238. 13. Harano Y, Ohgaku S, Kosugi K, Yasuda H, 4. Jackson WPU, Forman R (1966) Hyperosmolar Nakano T, Kobayashi M, Hidaka K, Izumi K, nonketotic diabetic coma. Diabetes 15: 714-722. Kashiwagi A, Shigeta Y (1981) Clinical significance 5. Khardori R, Soler NG (1984) Hyperosmolar of altered insulin sensitivity in diabetes mellitus hyperglycemic non ketotic syndrome. AmJ Med 77: assessed by glucose, insulin, and somatostatin 899-904. infusion. J Clin Endocrinol Metab 52: 982-987. 6. Keller U, Berger W, Ritz R, Truog P (1974) Course 14. Halperin ML, Marsden PA, Singer GG, West ML and prognosis of 86 episodes of diabetic coma. A (1985). Can marked hyperglycemia occur without fove year experience with a uniform schedule of ketosis? Clin Inv Med 8: 253-256. treatment. Diabetologia 11: 93-100. 15. Davidson JK (1983) Diabetic ketoacidosis and the 7. Kida Y, Sawada T, Narutomi H, Harano Y, hyperglycemic hyperosmolar state. ClinicalDiabetes Kashiwagi A, Shigeta Y (1988) A case of nonketotic Mellitus 21: 300-316. hyperosmolar coma with sensory aphasia, focal 16. Stephens JM, Sulway MJ, Watkins PJ (1971) seizure and hemiparesis. Jpn J Med 77: 74-79. Relationship of blood acetoacetate and 3- 8. Joffe BI, Seftel HC, Goldberg R, Van As M, Krut hydroxybutyrate in diabetes. Diabetes20: 485-489. L, Bersohn I (1973) Factors in the pathogenesis of 17. Yamamoto T (1982) Diabetic ketoacidosis in a experimental nonketotic and ketoacidotic diabetic community of suburban Osaka. Analysis of 39 stupor. Diabetes 22: 653-657. episodes of ketoacidosis and related conditions. 9. Gerich J, Penhos JC, Gutman RA, Recant L (1973) EndocrinolJapon 30: 43-54. Effect of dehydration and hyperosmolarity on 18. Harano Y, Suzuki M, Kojima H, Kashiwagi A, glucose, fatty acid and ketone body metabolism in Hidaka H, Shigeta Y (1984) Development of the rat. Diabetes 22: 264-271. paper-strip test for 3-hydroxybutyrate and its 10. Kojima H, Harano Y, Kosugi K, Nakano T, clinical application. Diabetes Care 7: 481-485. Shigeta Y (1986) A suppressive role of c-kinase for 19. Harano Y, Aoki T, Nakajima Y, Kojima H, Kosugi the stimulation of hepatic ketogenesis by glucagon K, Harano A, Hidaka H, Yamada S, Uno S, Shigeta and epinephrine. FEBS Letters 201: 271-276. Y (1990) Development of stable film test for rapid 11. Harano Y, Hibi A, Kojima H, Hidaka H, Shigeta Y estimation of blood or plasma 3-hydroxybutyrate. (1988) Role of vasopressin in the pathophysiology Diabetes Care 13: 522-524. of non-ketotic hyperosmolar diabetic coma. In: